Find market predictions, MAYBAKER financials and market news.
Company History - Piramal Enterprises Ltd. 1947 - The Company was incorporated on 26th April, under the name of Indian Schering, Ltd., U.K. as a subsidiary of British Schering, Ltd. 1957 - E. Griffiths Hughes, Ltd. of which British Schering, Ltd., U.K. was a subsidiary was taken over by Aspro-Nicholas, Ltd., U.K. Welcome to May & Baker Nigeria Plc May & Baker Nigeria Plc was founded on September 4, 1944 as Nigeria's first pharmaceutical company. Its authorized share capital is Rs. May And Baker (india) Ltd. is a Public incorporated on 01 January 2000. She noted that the healthcare space in sub Saharan Africa (SSA) is still largely untapped and an investment haven for operators like May and Baker.
The issued and paid up share capital of the Company currently is N490,000,000 ... May & Baker Nigeria Plc RC.
The attraction of May and Baker as an investment haven lies not only in her long track record of robust performance but more in her future prospects,' Danjuma said.According to him, distribution expenses came down from N1.434 billion in 2018 to N1.197 billion in 2019. Brands listed with corresponding Generic name and price details. View the latest May & Baker Nigeria PLC (MAYBAKER.NG) stock price, news, historical charts, analyst ratings and financial information from WSJ.
0. May & Baker Pharmaceuticals Ltd brand List that includes tablets, capsules, syrups, etc. the Authorized share capital of the Company is N1,900,000,000 divided into 3,800,000,000 ordinary shares of 50 kobo each.
0 and its paid up capital is Rs. Reviews from May & Baker Nigeria Plc employees about May & Baker Nigeria Plc culture, salaries, benefits, work-life balance, management, job security, and more.
May & Baker Nigeria Plc is a pharmaceutical company. Since then, the principal owners of the Company belonged to the …
3. Data may be intentionally delayed pursuant to supplier requirements.
The firm operates through following segments: Pharmaceuticals and Beverage. May & Baker was a British chemical company..
558 REPORT OF THE AUDIT COMMITTEE In accordance with the provisions of Section 359(6) of the Companies and Allied FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom.
According to a disclosure issued to the Nigerian Stock Exchange, the payment will be subject to shareholders’ approval and appropriate withholding tax. May & Baker Pharmaceuticals Ltd Office No.B7 Laxmi Tower Local Shopping Complex, Opposite Mother Dairy, Saraswati Vihar, Delhi-110034, India
May and Baker Nigeria Plc is a diversified group organized around 2 areas of activity: - manufacturing of pharmaceutical products and vaccines (99.2% of net sales); - manufacturing and distribution of mineral water (0.8%): Lily brand. 'I see a great future for our company. Shareholders of May and Baker Nigeria Plc at the weekend received a total of N431.31 million as cash dividends for the 2019 business year.
It has its origin in England, the United Kingdom in 1834 where three chemists founded Grimwade, May & Pickett, a firm for manufacturing chemicals for pharmaceutical products.
View live MAY AND BAKER PLC - NIGERIA chart to track its stock's price action. It engages in the manufacture, sale, and distribution of pharmaceuticals and consumer products. The Management and Board of May & Baker Nigeria Plc, today, announced dividend payment of 20 kobo per 50 kobo share. The distribution followed approval of a 25 per cent increase in dividend payout by shareholders at the annual general meeting of the company. They initially specialized in the manufacture of chemicals derived from Mercury and Bismuth.Over the years they diversified into other chemical fields including Photographic, Pharmaceuticals, Agrochemicals, and chemicals for Research and … It was started by John May and William Gerrard Baker in Wandsworth, London in 1839. The Pharmaceuticals segment involves in the...Data are provided 'as is' for informational purposes only and are not intended for trading purposes.
MAY & BAKER NIGERIA PLC CONSOLIDATED STATEMENT OF CHANGES IN EQUITY FOR THE YEAR ENDED 31 DECEMBER 2013 Share Capital Share Premium Account Retained Earnings Total N'000 N'000 N'000 N'000 Equity attributable to equity holders of the Group 490,000 1,626,094 1,038,259 3,154,353 - - 75,943 75,943